title: Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
abstract: We report a case of varicella-zoster virus (VZV) myelitis in a woman with relapsing-remitting multiple sclerosis (RRMS) receiving natalizumab, a humanized monoclonal antibody that induces an immunosuppression localized to the CNS.
authors.affiliation: AP-HP, Hôpital Bicêtre, France.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Yeung
authors.forename: Cécile
authors.initials: C
authors.lastname: Cauquil
authors.forename: Guillaume
authors.initials: G
authors.lastname: Saliou
authors.forename: Ghaida
authors.initials: G
authors.lastname: Nasser
authors.forename: Sophio
authors.initials: S
authors.lastname: Rostomashvili
authors.forename: David
authors.initials: D
authors.lastname: Adams
authors.forename: Marie
authors.initials: M
authors.lastname: Théaudin
mesh_terms: D000208:Acute Disease; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006562:Herpes Zoster / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis*; D014645:Herpesvirus 3, Human / Q000472:pathogenicity*; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis*; D009187:Myelitis / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis*; D000069442:Natalizumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab